CliffBio
small molecule

ISOPROTERENOL HYDROCHLORIDE

ISOPROTERENOL HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyAmphastar Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameISOPROTERENOL HYDROCHLORIDE
Active ingredientISOPROTERENOL HYDROCHLORIDE
Strength0.2MG/ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalJune 2018
Marketing statusRX

More from Amphastar Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

ISOPROTERENOL HYDROCHLORIDE patent cliff — loss of exclusivity — | CliffBio